Anzeige
Mehr »
Login
Dienstag, 21.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Aktienchance des Jahres! Ihre Chance auf explosive Gewinne!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0B5TU | ISIN: GB00B012TP20 | Ticker-Symbol: HDK
München
20.01.25
08:05 Uhr
1,500 Euro
0,000
0,00 %
Branche
Handel/E-Commerce
Aktienmarkt
Sonstige
1-Jahres-Chart
HALFORDS GROUP PLC Chart 1 Jahr
5-Tage-Chart
HALFORDS GROUP PLC 5-Tage-Chart
RealtimeGeldBriefZeit
1,4601,55020.01.
Dow Jones News
393 Leser
Artikel bewerten:
(2)

Halfords Group PLC: Director/PDMR Shareholding

Finanznachrichten News

DJ Halfords Group PLC: Director/PDMR Shareholding

Halfords Group PLC (HFD) 
Halfords Group PLC: Director/PDMR Shareholding 
05-Dec-2024 / 14:45 GMT/BST 
=---------------------------------------------------------------------------------------------------------------------- 
The notification set out below is provided in accordance with the requirements of the UK Market Abuse Regulation 
 
1.      Details of PDMR / person closely associated with them ('PCA') 
a)      Name                    Graham Stapleton 
b)      Position / status             PDMR (Chief Executive Officer) 
c)      Initial notification / amendment      Initial Notification 
2.      Details of the issuer 
       Name                    Halfords Group plc 
3.      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where transactions have been conducted 
                             Ordinary 1p shares 
a)      Description of the financial instrument 
                             ISIN: GB00B012TP20 
b)      Nature of the transaction         Grant of 857,800 shares under the Performance Share Plan 
                             Price(s)    Volume(s) 
c)      Price(s) and volume(s)           GBP1.481     857,800 

Aggregated information n/a single transaction

d)

Aggregated volume Price n/a single transaction

e) Date of the transaction 2024-12-03

f) Place of the transaction London Stock Exchange, Main Market (XLON)

1.      Details of PDMR / person closely associated with them ('PCA') 
a)      Name                    Johanna Hartley 
b)      Position / status             PDMR (Chief Financial Officer) 
c)      Initial notification / amendment      Initial Notification 
2.      Details of the issuer 
       Name                    Halfords Group plc 
3.      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where transactions have been conducted 
                             Ordinary 1p shares 
a)      Description of the financial instrument 
                             ISIN: GB00B012TP20 
b)      Nature of the transaction         Grant of 565,908 shares under the Performance Share Plan 
                             Price(s)    Volume(s) 
c)      Price(s) and volume(s)           GBP1.481     565,908 

Aggregated information n/a single transaction

d)

Aggregated volume Price n/a single transaction

e) Date of the transaction 2024-12-03

f) Place of the transaction London Stock Exchange, Main Market (XLON)

1.      Details of PDMR / person closely associated with them ('PCA') 
a)      Name            Karen Bellairs 
b)      Position / status     PDMR (Group Chief Customer and Commercial Officer) 
c)      Initial notification /   Initial Notification 
       amendment 
2.      Details of the issuer 
       Name            Halfords Group plc 
3.      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where transactions have been conducted 
       Description of the     Ordinary 1p shares 
a)      financial instrument 
                     ISIN: GB00B012TP20 
b)      Nature of the transaction Grant of 233,643 shares under the Performance Share Plan and grant of 43,173 
                     shares under the Restricted Share Plan 
                     Price(s)    Volume(s) 
c)      Price(s) and volume(s)   GBP1.481     276,816 

Aggregated information n/a single transaction

d)

Aggregated volume Price n/a single transaction

e) Date of the transaction 2024-12-03

f) Place of the London Stock Exchange, Main Market (XLON)

transaction

1.      Details of PDMR / person closely associated with them ('PCA') 
a)      Name            Paul O'Hara 
b)      Position / status     PDMR (Chief People and Property Officer) 
c)      Initial notification /   Initial Notification 
       amendment 
2.      Details of the issuer 
       Name            Halfords Group plc 
3.      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where transactions have been conducted 
       Description of the     Ordinary 1p shares 
a)      financial instrument 
                     ISIN: GB00B012TP20 
b)      Nature of the transaction Grant of 103,153 shares under the Performance Share Plan and grant of 34,384 
                     shares under the Restricted Share Plan 
                     Price(s)    Volume(s) 
c)      Price(s) and volume(s)   GBP1.481     137,537 

Aggregated information n/a single transaction

d)

Aggregated volume Price n/a single transaction

e) Date of the transaction 2024-12-03

f) Place of the London Stock Exchange, Main Market (XLON)

transaction

1.      Details of PDMR / person closely associated with them ('PCA') 
a)      Name            Adam Gerrard 
b)      Position / status     PDMR (Chief Information Officer) 
c)      Initial notification /   Initial Notification 
       amendment 
2.      Details of the issuer 
       Name            Halfords Group plc 
3.      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where transactions have been conducted 
       Description of the     Ordinary 1p shares 
a)      financial instrument 
                     ISIN: GB00B012TP20 
b)      Nature of the transaction Grant of 121,539 shares under the Performance Share Plan and grant of 40,513 
                     shares under the Restricted Share Plan 
                     Price(s)    Volume(s) 
c)      Price(s) and volume(s)   GBP1.481     162,052 

Aggregated information n/a single transaction

d)

Aggregated volume Price n/a single transaction

e) Date of the transaction 2024-12-03

f) Place of the London Stock Exchange, Main Market (XLON)

transaction

1.      Details of PDMR / person closely associated with them ('PCA') 
a)      Name             Tim O'Gorman 
b)      Position / status       PDMR (General Counsel and Company Secretary) 
c)      Initial notification /    Initial Notification 
       amendment 
2.      Details of the issuer 
       Name             Halfords Group plc 
3.      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where transactions have been conducted 
       Description of the financial Ordinary 1p shares 
a)      instrument 
                      ISIN: GB00B012TP20 
b)      Nature of the transaction   Grant of 26,074 shares under the Performance Share Plan and 19,556 shares 
                      under the Restricted Share Plan 
                      Price(s)    Volume(s) 
c)      Price(s) and volume(s)    GBP1.481     45,630 

Aggregated information n/a single transaction

d)

Aggregated volume Price n/a single transaction

e) Date of the transaction 2024-12-03

f) Place of the transaction London Stock Exchange, Main Market (XLON)

1.      Details of PDMR / person closely associated with them ('PCA') 
a)      Name            Chris McShane 
b)      Position / status     PDMR (Director of B2B Operations and Avayler) 
c)      Initial notification /   Initial Notification 
       amendment 
2.      Details of the issuer 
       Name            Halfords Group plc 
3.      Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place where transactions have been conducted 
       Description of the     Ordinary 1p shares 
a)      financial instrument 
                     ISIN: GB00B012TP20 
b)      Nature of the transaction Grant of 107,359 shares under the Performance Share Plan and grant of 35,786 
                     shares under the Restricted Share Plan 
                     Price(s)    Volume(s) 
c)      Price(s) and volume(s)   GBP1.481     143,145 

Aggregated information n/a single transaction

d)

Aggregated volume Price n/a single transaction

e) Date of the transaction 2024-12-03

f) Place of the London Stock Exchange, Main Market (XLON)

transaction

----------------------------------------------------------------------------------------------------------------------- Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

ISIN:      GB00B012TP20 
Category Code: DSH 
TIDM:      HFD 
LEI Code:    54930086FKBWWJIOBI79 
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State 
Sequence No.:  363476 
EQS News ID:  2045321 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=2045321&application_name=news&site_id=dow_jones%7e%7e%7ef1066a31-ca00-4e1a-b0a4-374bd7d0face

(END) Dow Jones Newswires

December 05, 2024 09:45 ET (14:45 GMT)

© 2024 Dow Jones News
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.